skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: A systematic review and meta-analysis

Medicine (Baltimore), 2021-02, Vol.100 (5), p.e24557-e24557 [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000024557 ;PMID: 33592910

Full text available

Citations Cited by
  • Title:
    Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: A systematic review and meta-analysis
  • Author: Saokaew, Surasak ; Kanchanasurakit, Sukrit ; Thawichai, Kanitta ; Duangprom, Prommanee ; Wannasri, Monnapha ; Khankham, Sirintip ; Kositamongkol, Chayanis ; Chaiyakunapruk, Nathorn ; Phisalprapa, Pochamana
  • Subjects: Age Factors ; Aged ; Aged, 80 and over ; Cardiovascular Diseases - epidemiology ; Cigarette Smoking - epidemiology ; Comorbidity ; Female ; Hospitalization - statistics & numerical data ; Humans ; Lipids - blood ; Male ; Middle Aged ; Mortality - trends ; Non-alcoholic Fatty Liver Disease - epidemiology ; Risk Factors ; Sex Factors ; Systematic Review and Meta-Analysis
  • Is Part Of: Medicine (Baltimore), 2021-02, Vol.100 (5), p.e24557-e24557
  • Description: Controversy remains concerning the association of the all-cause mortality risk of hospitalized cardiovascular disease (CVD) patients with non-alcoholic fatty liver disease (NAFLD). This study investigated the risks of all-cause mortality among hospitalized CVD patients with NAFLD. We used related keywords to search for studies in 3 electronic databases: PubMed, EMBASE, and Cochrane Library. All eligible studies published up to April 2020 were reviewed. The findings of those studies reporting the mortality outcomes of hospitalized CVD patients with and without NAFLD were examined, and the various study results were pooled and analyzed using a random-effects model. A quality assessment using the Newcastle-Ottawa scale was performed on the studies selected for inclusion in a meta-analysis. A total of 2135 studies were found, of which 3 were included in this meta-analysis. All studies were considered good quality. The mean age of the patients in the analysis was 73 years, and about half of them were men. The comorbidities reported were hypertension, diabetes mellitus, and dyslipidemia. The results showed that hospitalized CVD patients with NAFLD were at a significantly higher risk of all-cause mortality than non-NAFLD patients (adjusted hazard ratio of 2.08 [95% confidence interval, 1.56-2.59], P < .001). The included studies showed low heterogeneity (I2 = 0.0%, P = .473), and Begg and Egger tests revealed no apparent publication bias (P = .327 and P = .682, respectively). Hospitalized CVD patients with NAFLD were at a higher risk of all-cause mortality than those without NAFLD. More studies that further explore this association are needed.
  • Publisher: United States: Lippincott Williams & Wilkins
  • Language: English
  • Identifier: ISSN: 0025-7974
    EISSN: 1536-5964
    DOI: 10.1097/MD.0000000000024557
    PMID: 33592910
  • Source: IngentaConnect Free/Open Access Journals
    Journals@Ovid Open Access Journal Collection Rolling
    Wolters Kluwer Open Health
    MEDLINE
    PubMed Central
    DOAJ Directory of Open Access Journals

Searching Remote Databases, Please Wait